cephalosporin c has been researched along with garenoxacin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Funaishi, K; Hattori, N; Katsutani, S; Kawamoto, K; Matsumoto, N; Matsumoto, Y; Ohashi, N; Taniwaki, M; Yamasaki, M | 1 |
Imuta, N; Iuchi, H; Kiyama, S; Kurono, Y; Nishi, J; Ohori, J; Yamashita, M | 1 |
2 other study(ies) available for cephalosporin c and garenoxacin
Article | Year |
---|---|
Acquired factor V inhibitor after antibiotic treatment in a patient with pneumonia: a case report.
Topics: Aged; Anti-Bacterial Agents; Antibody Specificity; Antifungal Agents; Autoantibodies; Autoimmune Diseases; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Substitution; Drug Therapy, Combination; Factor V; Factor V Deficiency; Fluoroquinolones; Humans; Levofloxacin; Male; Meropenem; Micafungin; Partial Thromboplastin Time; Pneumonia; Prothrombin Time | 2019 |
Effectiveness of antibacterial agents against cell-invading bacteria such as Streptococcus pyogenes and Haemophilus influenzae.
Topics: Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Clarithromycin; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Streptococcal Infections; Streptococcus pyogenes | 2021 |